Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000596467 | SCV000700581 | likely benign | not specified | 2017-05-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001084350 | SCV000770693 | benign | Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 3 | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000762071 | SCV000892326 | likely benign | not provided | 2021-08-01 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000762071 | SCV005210457 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Genome Diagnostics Laboratory, |
RCV000596467 | SCV001928374 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000596467 | SCV001974364 | benign | not specified | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003912439 | SCV004736894 | likely benign | NCF4-related disorder | 2020-05-26 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |